Global Nuclear Medicine Radioisotope Production Systems Supply, Demand and Key Producers, 2026-2032
The global Nuclear Medicine Radioisotope Production Systems market size is expected to reach $ 1991 million by 2032, rising at a market growth of 9.7% CAGR during the forecast period (2026-2032).
Nuclear Medicine Radioisotope Production Systems are integrated system level equipment used to produce, separate, process and prepare medical radionuclides for nuclear medicine diagnosis, therapy and radiopharmaceutical research. Their core function is to convert stable target materials, parent nuclides or precursor materials into clinically usable medical radioisotopes through particle acceleration, target irradiation, reactor neutron irradiation, generator elution, radiochemical separation, shielded transfer and automated dispensing. These systems mainly cover medical cyclotron systems, solid target systems, liquid target systems, gas target systems, radionuclide transfer systems, hot cells, shielded isolators, automated dispensing units, radiochemistry synthesis modules, generator and separation modules, quality control units, radiation monitoring devices, safety interlock systems and clean production infrastructure. Key specifications include particle energy, beam current, target power handling capacity, isotope yield, radiochemical purity, automation level, shielding thickness, cleanroom grade, system availability, remote maintenance capability and GMP compatibility. The main applications include PET diagnostic isotope production, SPECT diagnostic isotope production, therapeutic isotope production, parent isotope preparation, on site production in hospital nuclear medicine centers, regional supply by commercial radiopharmacies, national isotope center construction and translational research for radiopharmaceuticals. The product is positioned as a high reliability and high compliance production system rather than a single laboratory instrument, because it combines nuclear engineering, radiation protection, radiochemistry, pharmaceutical manufacturing and digital quality management. In 2025, the global average price of Nuclear Medicine Radioisotope Production Systems was approximately USD 2.5 million to USD 8.0 million per unit, the number of new and upgraded equivalent system units was about 150 to 220 units, and the global average gross margin was about 35% to 50%.
Nuclear Medicine Radioisotope Production Systems are positioned in the midstream equipment layer of the nuclear medicine value chain. The upstream side includes accelerator components, target materials, shielding materials, vacuum systems, RF systems, magnets, power supplies, hot cell materials, automation control, cleanroom engineering and quality control instruments. The midstream layer consists of radionuclide production systems, target systems, hot cells, generator platforms, separation modules and integrated production lines. The downstream side includes hospital nuclear medicine departments, commercial radiopharmacies, national isotope centers, radiopharmaceutical research organizations and therapeutic radiopharmaceutical production sites. The strategic value of this industry is not limited to the equipment itself. Its real value lies in the ability to create stable, safe and compliant isotope production capacity, while supporting the transition from diagnostic isotope supply to therapeutic isotope production and theranostic isotope platforms.
The global competitive landscape is shaped by both high technical specialization and regional supply chain restructuring. Europe, North America and Japan have accumulated strong capabilities in medical cyclotrons, high performance target systems, hot cells, radiochemistry automation and in reactor isotope production engineering. These regions still dominate the high end system and critical subsystem segments. China, parts of Asia and the Middle East are showing faster demand growth, supported by nuclear medicine center expansion, regional radiopharmacy construction, import substitution and broader healthcare infrastructure investment. As isotope supply security becomes a policy priority for healthcare systems and nuclear technology programs, more countries are investing in domestic production capacity. This trend is increasing the importance of localized, compact, modular and serviceable production systems.
The application structure is shifting from conventional PET diagnostic isotope production toward multi isotope production platforms. Historically, demand was mainly driven by routine PET and SPECT isotopes, with system configurations centered on low energy medical cyclotrons, hot cells and dispensing equipment. Current growth is increasingly linked to therapeutic isotopes, parent isotopes, solid target processing, generator separation and complete GMP production lines. Theranostic drugs, targeted radioligand therapy and the need for local supply of short lived isotopes are encouraging customers to move from single equipment purchases to system level investment. In the future product mix, high automation target systems, remote operated hot cells, digital batch records, automated synthesis and dispensing, and high activity handling capability will become more important.
Policy environment and capital expenditure cycles have a strong influence on this market. Medical isotope supply is connected with public health, nuclear safety, drug regulation, radiation protection and strategic supply security, so government support, nuclear facility licensing, hospital construction plans and radiopharmaceutical approval schedules all affect equipment procurement. Recent global isotope supply disruptions, aging reactor infrastructure, rising interest in therapeutic radiopharmaceuticals and the expansion of nuclear medicine services are moving the industry from occasional equipment purchases toward long term capacity building. The outlook is positive, but equipment market growth will not fully mirror the growth rate of radiopharmaceutical sales because system delivery cycles are long, installation and validation are complex, regulatory review is strict and customer capital spending is staged. Overall, the industry is expected to maintain steady growth, with high end system capability and localized supply support becoming the key competitive priorities.
This report studies the global Nuclear Medicine Radioisotope Production Systems production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine Radioisotope Production Systems and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine Radioisotope Production Systems that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine Radioisotope Production Systems total production and demand, 2021-2032, (Units)
Global Nuclear Medicine Radioisotope Production Systems total production value, 2021-2032, (USD Million)
Global Nuclear Medicine Radioisotope Production Systems production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Nuclear Medicine Radioisotope Production Systems consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Nuclear Medicine Radioisotope Production Systems domestic production, consumption, key domestic manufacturers and share
Global Nuclear Medicine Radioisotope Production Systems production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Nuclear Medicine Radioisotope Production Systems production by Production Route, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Nuclear Medicine Radioisotope Production Systems production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Nuclear Medicine Radioisotope Production Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ion Beam Applications SA, GE HealthCare Technologies Inc., Sumitomo Heavy Industries, Ltd., Advanced Cyclotron Systems Inc., Best Theratronics Ltd., PMB SAS, Sichuan Longevous Beamtech Co., Ltd., China Institute of Atomic Energy, ARTMS Inc., Comecer S.p.A., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Medicine Radioisotope Production Systems market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (K US$/Unit) by manufacturer, by Production Route, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nuclear Medicine Radioisotope Production Systems Market, By Region:
1. How big is the global Nuclear Medicine Radioisotope Production Systems market?
2. What is the demand of the global Nuclear Medicine Radioisotope Production Systems market?
3. What is the year over year growth of the global Nuclear Medicine Radioisotope Production Systems market?
4. What is the production and production value of the global Nuclear Medicine Radioisotope Production Systems market?
5. Who are the key producers in the global Nuclear Medicine Radioisotope Production Systems market?
6. What are the growth factors driving the market demand?
Nuclear Medicine Radioisotope Production Systems are integrated system level equipment used to produce, separate, process and prepare medical radionuclides for nuclear medicine diagnosis, therapy and radiopharmaceutical research. Their core function is to convert stable target materials, parent nuclides or precursor materials into clinically usable medical radioisotopes through particle acceleration, target irradiation, reactor neutron irradiation, generator elution, radiochemical separation, shielded transfer and automated dispensing. These systems mainly cover medical cyclotron systems, solid target systems, liquid target systems, gas target systems, radionuclide transfer systems, hot cells, shielded isolators, automated dispensing units, radiochemistry synthesis modules, generator and separation modules, quality control units, radiation monitoring devices, safety interlock systems and clean production infrastructure. Key specifications include particle energy, beam current, target power handling capacity, isotope yield, radiochemical purity, automation level, shielding thickness, cleanroom grade, system availability, remote maintenance capability and GMP compatibility. The main applications include PET diagnostic isotope production, SPECT diagnostic isotope production, therapeutic isotope production, parent isotope preparation, on site production in hospital nuclear medicine centers, regional supply by commercial radiopharmacies, national isotope center construction and translational research for radiopharmaceuticals. The product is positioned as a high reliability and high compliance production system rather than a single laboratory instrument, because it combines nuclear engineering, radiation protection, radiochemistry, pharmaceutical manufacturing and digital quality management. In 2025, the global average price of Nuclear Medicine Radioisotope Production Systems was approximately USD 2.5 million to USD 8.0 million per unit, the number of new and upgraded equivalent system units was about 150 to 220 units, and the global average gross margin was about 35% to 50%.
Nuclear Medicine Radioisotope Production Systems are positioned in the midstream equipment layer of the nuclear medicine value chain. The upstream side includes accelerator components, target materials, shielding materials, vacuum systems, RF systems, magnets, power supplies, hot cell materials, automation control, cleanroom engineering and quality control instruments. The midstream layer consists of radionuclide production systems, target systems, hot cells, generator platforms, separation modules and integrated production lines. The downstream side includes hospital nuclear medicine departments, commercial radiopharmacies, national isotope centers, radiopharmaceutical research organizations and therapeutic radiopharmaceutical production sites. The strategic value of this industry is not limited to the equipment itself. Its real value lies in the ability to create stable, safe and compliant isotope production capacity, while supporting the transition from diagnostic isotope supply to therapeutic isotope production and theranostic isotope platforms.
The global competitive landscape is shaped by both high technical specialization and regional supply chain restructuring. Europe, North America and Japan have accumulated strong capabilities in medical cyclotrons, high performance target systems, hot cells, radiochemistry automation and in reactor isotope production engineering. These regions still dominate the high end system and critical subsystem segments. China, parts of Asia and the Middle East are showing faster demand growth, supported by nuclear medicine center expansion, regional radiopharmacy construction, import substitution and broader healthcare infrastructure investment. As isotope supply security becomes a policy priority for healthcare systems and nuclear technology programs, more countries are investing in domestic production capacity. This trend is increasing the importance of localized, compact, modular and serviceable production systems.
The application structure is shifting from conventional PET diagnostic isotope production toward multi isotope production platforms. Historically, demand was mainly driven by routine PET and SPECT isotopes, with system configurations centered on low energy medical cyclotrons, hot cells and dispensing equipment. Current growth is increasingly linked to therapeutic isotopes, parent isotopes, solid target processing, generator separation and complete GMP production lines. Theranostic drugs, targeted radioligand therapy and the need for local supply of short lived isotopes are encouraging customers to move from single equipment purchases to system level investment. In the future product mix, high automation target systems, remote operated hot cells, digital batch records, automated synthesis and dispensing, and high activity handling capability will become more important.
Policy environment and capital expenditure cycles have a strong influence on this market. Medical isotope supply is connected with public health, nuclear safety, drug regulation, radiation protection and strategic supply security, so government support, nuclear facility licensing, hospital construction plans and radiopharmaceutical approval schedules all affect equipment procurement. Recent global isotope supply disruptions, aging reactor infrastructure, rising interest in therapeutic radiopharmaceuticals and the expansion of nuclear medicine services are moving the industry from occasional equipment purchases toward long term capacity building. The outlook is positive, but equipment market growth will not fully mirror the growth rate of radiopharmaceutical sales because system delivery cycles are long, installation and validation are complex, regulatory review is strict and customer capital spending is staged. Overall, the industry is expected to maintain steady growth, with high end system capability and localized supply support becoming the key competitive priorities.
This report studies the global Nuclear Medicine Radioisotope Production Systems production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine Radioisotope Production Systems and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine Radioisotope Production Systems that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine Radioisotope Production Systems total production and demand, 2021-2032, (Units)
Global Nuclear Medicine Radioisotope Production Systems total production value, 2021-2032, (USD Million)
Global Nuclear Medicine Radioisotope Production Systems production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Nuclear Medicine Radioisotope Production Systems consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Nuclear Medicine Radioisotope Production Systems domestic production, consumption, key domestic manufacturers and share
Global Nuclear Medicine Radioisotope Production Systems production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Nuclear Medicine Radioisotope Production Systems production by Production Route, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Nuclear Medicine Radioisotope Production Systems production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Nuclear Medicine Radioisotope Production Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ion Beam Applications SA, GE HealthCare Technologies Inc., Sumitomo Heavy Industries, Ltd., Advanced Cyclotron Systems Inc., Best Theratronics Ltd., PMB SAS, Sichuan Longevous Beamtech Co., Ltd., China Institute of Atomic Energy, ARTMS Inc., Comecer S.p.A., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Medicine Radioisotope Production Systems market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (K US$/Unit) by manufacturer, by Production Route, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nuclear Medicine Radioisotope Production Systems Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cyclotron based Production Systems
- Reactor Irradiation Production Systems
- Generator and Separation Production Systems
- Electron Accelerator and Neutron Source Production Systems
- Others
- Compact Low Energy Systems (?20 MeV)
- Medium Energy Multi Isotope Systems (20 to 35 MeV)
- High Energy Isotope Production Systems (>35 MeV)
- Others
- Hospital Nuclear Medicine Centers
- Commercial Radiopharmacies
- National Isotope Production Centers
- Research Institutes and Universities
- Nuclear Reactor Facilities
- Radiopharmaceutical CDMO Sites
- Others
- Ion Beam Applications SA
- GE HealthCare Technologies Inc.
- Sumitomo Heavy Industries, Ltd.
- Advanced Cyclotron Systems Inc.
- Best Theratronics Ltd.
- PMB SAS
- Sichuan Longevous Beamtech Co., Ltd.
- China Institute of Atomic Energy
- ARTMS Inc.
- Comecer S.p.A.
- Tema Sinergie S.p.A.
- Von Gahlen International B.V.
- Trasis S.A.
- Eckert & Ziegler Medical GmbH
- Kinectrics Inc.
- Framatome
- NorthStar Medical Radioisotopes, LLC
1. How big is the global Nuclear Medicine Radioisotope Production Systems market?
2. What is the demand of the global Nuclear Medicine Radioisotope Production Systems market?
3. What is the year over year growth of the global Nuclear Medicine Radioisotope Production Systems market?
4. What is the production and production value of the global Nuclear Medicine Radioisotope Production Systems market?
5. Who are the key producers in the global Nuclear Medicine Radioisotope Production Systems market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nuclear Medicine Radioisotope Production Systems Introduction
1.2 World Nuclear Medicine Radioisotope Production Systems Supply & Forecast
1.2.1 World Nuclear Medicine Radioisotope Production Systems Production Value (2021 & 2025 & 2032)
1.2.2 World Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.2.3 World Nuclear Medicine Radioisotope Production Systems Pricing Trends (2021-2032)
1.3 World Nuclear Medicine Radioisotope Production Systems Production by Region (Based on Production Site)
1.3.1 World Nuclear Medicine Radioisotope Production Systems Production Value by Region (2021-2032)
1.3.2 World Nuclear Medicine Radioisotope Production Systems Production by Region (2021-2032)
1.3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Region (2021-2032)
1.3.4 North America Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.3.5 Europe Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.3.6 China Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.3.7 Japan Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Medicine Radioisotope Production Systems Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nuclear Medicine Radioisotope Production Systems Major Market Trends
2 DEMAND SUMMARY
2.1 World Nuclear Medicine Radioisotope Production Systems Demand (2021-2032)
2.2 World Nuclear Medicine Radioisotope Production Systems Consumption by Region
2.2.1 World Nuclear Medicine Radioisotope Production Systems Consumption by Region (2021-2026)
2.2.2 World Nuclear Medicine Radioisotope Production Systems Consumption Forecast by Region (2027-2032)
2.3 United States Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.4 China Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.5 Europe Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.6 Japan Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.7 South Korea Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.8 ASEAN Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.9 India Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nuclear Medicine Radioisotope Production Systems Production Value by Manufacturer (2021-2026)
3.2 World Nuclear Medicine Radioisotope Production Systems Production by Manufacturer (2021-2026)
3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Manufacturer (2021-2026)
3.4 Nuclear Medicine Radioisotope Production Systems Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nuclear Medicine Radioisotope Production Systems Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nuclear Medicine Radioisotope Production Systems in 2025
3.5.3 Global Concentration Ratios (CR8) for Nuclear Medicine Radioisotope Production Systems in 2025
3.6 Nuclear Medicine Radioisotope Production Systems Market: Overall Company Footprint Analysis
3.6.1 Nuclear Medicine Radioisotope Production Systems Market: Region Footprint
3.6.2 Nuclear Medicine Radioisotope Production Systems Market: Company Product Type Footprint
3.6.3 Nuclear Medicine Radioisotope Production Systems Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Value Comparison
4.1.1 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Comparison
4.2.1 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Nuclear Medicine Radioisotope Production Systems Consumption Comparison
4.3.1 United States VS China: Nuclear Medicine Radioisotope Production Systems Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Nuclear Medicine Radioisotope Production Systems Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Nuclear Medicine Radioisotope Production Systems Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value (2021-2026)
4.4.3 United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production (2021-2026)
4.5 China Based Nuclear Medicine Radioisotope Production Systems Manufacturers and Market Share
4.5.1 China Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value (2021-2026)
4.5.3 China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production (2021-2026)
4.6 Rest of World Based Nuclear Medicine Radioisotope Production Systems Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production (2021-2026)
5 MARKET ANALYSIS BY PRODUCTION ROUTE
5.1 World Nuclear Medicine Radioisotope Production Systems Market Size Overview by Production Route: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Production Route
5.2.1 Cyclotron based Production Systems
5.2.2 Reactor Irradiation Production Systems
5.2.3 Generator and Separation Production Systems
5.2.4 Electron Accelerator and Neutron Source Production Systems
5.2.5 Others
5.3 Market Segment by Production Route
5.3.1 World Nuclear Medicine Radioisotope Production Systems Production by Production Route (2021-2032)
5.3.2 World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route (2021-2032)
5.3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2032)
6 MARKET ANALYSIS BY ENERGY LEVEL
6.1 World Nuclear Medicine Radioisotope Production Systems Market Size Overview by Energy Level: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Energy Level
6.2.1 Compact Low Energy Systems (?20 MeV)
6.2.2 Medium Energy Multi Isotope Systems (20 to 35 MeV)
6.2.3 High Energy Isotope Production Systems (>35 MeV)
6.2.4 Others
6.3 Market Segment by Energy Level
6.3.1 World Nuclear Medicine Radioisotope Production Systems Production by Energy Level (2021-2032)
6.3.2 World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level (2021-2032)
6.3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Energy Level (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Nuclear Medicine Radioisotope Production Systems Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital Nuclear Medicine Centers
7.2.2 Commercial Radiopharmacies
7.2.3 National Isotope Production Centers
7.2.4 Research Institutes and Universities
7.2.5 Nuclear Reactor Facilities
7.2.6 Radiopharmaceutical CDMO Sites
7.2.7 Others
7.3 Market Segment by Application
7.3.1 World Nuclear Medicine Radioisotope Production Systems Production by Application (2021-2032)
7.3.2 World Nuclear Medicine Radioisotope Production Systems Production Value by Application (2021-2032)
7.3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Ion Beam Applications SA
8.1.1 Ion Beam Applications SA Details
8.1.2 Ion Beam Applications SA Major Business
8.1.3 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product and Services
8.1.4 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Ion Beam Applications SA Recent Developments/Updates
8.1.6 Ion Beam Applications SA Competitive Strengths & Weaknesses
8.2 GE HealthCare Technologies Inc.
8.2.1 GE HealthCare Technologies Inc. Details
8.2.2 GE HealthCare Technologies Inc. Major Business
8.2.3 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
8.2.4 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 GE HealthCare Technologies Inc. Recent Developments/Updates
8.2.6 GE HealthCare Technologies Inc. Competitive Strengths & Weaknesses
8.3 Sumitomo Heavy Industries, Ltd.
8.3.1 Sumitomo Heavy Industries, Ltd. Details
8.3.2 Sumitomo Heavy Industries, Ltd. Major Business
8.3.3 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
8.3.4 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Sumitomo Heavy Industries, Ltd. Recent Developments/Updates
8.3.6 Sumitomo Heavy Industries, Ltd. Competitive Strengths & Weaknesses
8.4 Advanced Cyclotron Systems Inc.
8.4.1 Advanced Cyclotron Systems Inc. Details
8.4.2 Advanced Cyclotron Systems Inc. Major Business
8.4.3 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
8.4.4 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Advanced Cyclotron Systems Inc. Recent Developments/Updates
8.4.6 Advanced Cyclotron Systems Inc. Competitive Strengths & Weaknesses
8.5 Best Theratronics Ltd.
8.5.1 Best Theratronics Ltd. Details
8.5.2 Best Theratronics Ltd. Major Business
8.5.3 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
8.5.4 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Best Theratronics Ltd. Recent Developments/Updates
8.5.6 Best Theratronics Ltd. Competitive Strengths & Weaknesses
8.6 PMB SAS
8.6.1 PMB SAS Details
8.6.2 PMB SAS Major Business
8.6.3 PMB SAS Nuclear Medicine Radioisotope Production Systems Product and Services
8.6.4 PMB SAS Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 PMB SAS Recent Developments/Updates
8.6.6 PMB SAS Competitive Strengths & Weaknesses
8.7 Sichuan Longevous Beamtech Co., Ltd.
8.7.1 Sichuan Longevous Beamtech Co., Ltd. Details
8.7.2 Sichuan Longevous Beamtech Co., Ltd. Major Business
8.7.3 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
8.7.4 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Sichuan Longevous Beamtech Co., Ltd. Recent Developments/Updates
8.7.6 Sichuan Longevous Beamtech Co., Ltd. Competitive Strengths & Weaknesses
8.8 China Institute of Atomic Energy
8.8.1 China Institute of Atomic Energy Details
8.8.2 China Institute of Atomic Energy Major Business
8.8.3 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product and Services
8.8.4 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 China Institute of Atomic Energy Recent Developments/Updates
8.8.6 China Institute of Atomic Energy Competitive Strengths & Weaknesses
8.9 ARTMS Inc.
8.9.1 ARTMS Inc. Details
8.9.2 ARTMS Inc. Major Business
8.9.3 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
8.9.4 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 ARTMS Inc. Recent Developments/Updates
8.9.6 ARTMS Inc. Competitive Strengths & Weaknesses
8.10 Comecer S.p.A.
8.10.1 Comecer S.p.A. Details
8.10.2 Comecer S.p.A. Major Business
8.10.3 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
8.10.4 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Comecer S.p.A. Recent Developments/Updates
8.10.6 Comecer S.p.A. Competitive Strengths & Weaknesses
8.11 Tema Sinergie S.p.A.
8.11.1 Tema Sinergie S.p.A. Details
8.11.2 Tema Sinergie S.p.A. Major Business
8.11.3 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
8.11.4 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Tema Sinergie S.p.A. Recent Developments/Updates
8.11.6 Tema Sinergie S.p.A. Competitive Strengths & Weaknesses
8.12 Von Gahlen International B.V.
8.12.1 Von Gahlen International B.V. Details
8.12.2 Von Gahlen International B.V. Major Business
8.12.3 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product and Services
8.12.4 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Von Gahlen International B.V. Recent Developments/Updates
8.12.6 Von Gahlen International B.V. Competitive Strengths & Weaknesses
8.13 Trasis S.A.
8.13.1 Trasis S.A. Details
8.13.2 Trasis S.A. Major Business
8.13.3 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product and Services
8.13.4 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Trasis S.A. Recent Developments/Updates
8.13.6 Trasis S.A. Competitive Strengths & Weaknesses
8.14 Eckert & Ziegler Medical GmbH
8.14.1 Eckert & Ziegler Medical GmbH Details
8.14.2 Eckert & Ziegler Medical GmbH Major Business
8.14.3 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product and Services
8.14.4 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.14.5 Eckert & Ziegler Medical GmbH Recent Developments/Updates
8.14.6 Eckert & Ziegler Medical GmbH Competitive Strengths & Weaknesses
8.15 Kinectrics Inc.
8.15.1 Kinectrics Inc. Details
8.15.2 Kinectrics Inc. Major Business
8.15.3 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
8.15.4 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.15.5 Kinectrics Inc. Recent Developments/Updates
8.15.6 Kinectrics Inc. Competitive Strengths & Weaknesses
8.16 Framatome
8.16.1 Framatome Details
8.16.2 Framatome Major Business
8.16.3 Framatome Nuclear Medicine Radioisotope Production Systems Product and Services
8.16.4 Framatome Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.16.5 Framatome Recent Developments/Updates
8.16.6 Framatome Competitive Strengths & Weaknesses
8.17 NorthStar Medical Radioisotopes, LLC
8.17.1 NorthStar Medical Radioisotopes, LLC Details
8.17.2 NorthStar Medical Radioisotopes, LLC Major Business
8.17.3 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product and Services
8.17.4 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.17.5 NorthStar Medical Radioisotopes, LLC Recent Developments/Updates
8.17.6 NorthStar Medical Radioisotopes, LLC Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Nuclear Medicine Radioisotope Production Systems Industry Chain
9.2 Nuclear Medicine Radioisotope Production Systems Upstream Analysis
9.2.1 Nuclear Medicine Radioisotope Production Systems Core Raw Materials
9.2.2 Main Manufacturers of Nuclear Medicine Radioisotope Production Systems Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Nuclear Medicine Radioisotope Production Systems Production Mode
9.6 Nuclear Medicine Radioisotope Production Systems Procurement Model
9.7 Nuclear Medicine Radioisotope Production Systems Industry Sales Model and Sales Channels
9.7.1 Nuclear Medicine Radioisotope Production Systems Sales Model
9.7.2 Nuclear Medicine Radioisotope Production Systems Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Nuclear Medicine Radioisotope Production Systems Introduction
1.2 World Nuclear Medicine Radioisotope Production Systems Supply & Forecast
1.2.1 World Nuclear Medicine Radioisotope Production Systems Production Value (2021 & 2025 & 2032)
1.2.2 World Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.2.3 World Nuclear Medicine Radioisotope Production Systems Pricing Trends (2021-2032)
1.3 World Nuclear Medicine Radioisotope Production Systems Production by Region (Based on Production Site)
1.3.1 World Nuclear Medicine Radioisotope Production Systems Production Value by Region (2021-2032)
1.3.2 World Nuclear Medicine Radioisotope Production Systems Production by Region (2021-2032)
1.3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Region (2021-2032)
1.3.4 North America Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.3.5 Europe Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.3.6 China Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.3.7 Japan Nuclear Medicine Radioisotope Production Systems Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Medicine Radioisotope Production Systems Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nuclear Medicine Radioisotope Production Systems Major Market Trends
2 DEMAND SUMMARY
2.1 World Nuclear Medicine Radioisotope Production Systems Demand (2021-2032)
2.2 World Nuclear Medicine Radioisotope Production Systems Consumption by Region
2.2.1 World Nuclear Medicine Radioisotope Production Systems Consumption by Region (2021-2026)
2.2.2 World Nuclear Medicine Radioisotope Production Systems Consumption Forecast by Region (2027-2032)
2.3 United States Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.4 China Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.5 Europe Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.6 Japan Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.7 South Korea Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.8 ASEAN Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
2.9 India Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nuclear Medicine Radioisotope Production Systems Production Value by Manufacturer (2021-2026)
3.2 World Nuclear Medicine Radioisotope Production Systems Production by Manufacturer (2021-2026)
3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Manufacturer (2021-2026)
3.4 Nuclear Medicine Radioisotope Production Systems Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nuclear Medicine Radioisotope Production Systems Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nuclear Medicine Radioisotope Production Systems in 2025
3.5.3 Global Concentration Ratios (CR8) for Nuclear Medicine Radioisotope Production Systems in 2025
3.6 Nuclear Medicine Radioisotope Production Systems Market: Overall Company Footprint Analysis
3.6.1 Nuclear Medicine Radioisotope Production Systems Market: Region Footprint
3.6.2 Nuclear Medicine Radioisotope Production Systems Market: Company Product Type Footprint
3.6.3 Nuclear Medicine Radioisotope Production Systems Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Value Comparison
4.1.1 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Comparison
4.2.1 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Nuclear Medicine Radioisotope Production Systems Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Nuclear Medicine Radioisotope Production Systems Consumption Comparison
4.3.1 United States VS China: Nuclear Medicine Radioisotope Production Systems Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Nuclear Medicine Radioisotope Production Systems Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Nuclear Medicine Radioisotope Production Systems Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value (2021-2026)
4.4.3 United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production (2021-2026)
4.5 China Based Nuclear Medicine Radioisotope Production Systems Manufacturers and Market Share
4.5.1 China Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value (2021-2026)
4.5.3 China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production (2021-2026)
4.6 Rest of World Based Nuclear Medicine Radioisotope Production Systems Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production (2021-2026)
5 MARKET ANALYSIS BY PRODUCTION ROUTE
5.1 World Nuclear Medicine Radioisotope Production Systems Market Size Overview by Production Route: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Production Route
5.2.1 Cyclotron based Production Systems
5.2.2 Reactor Irradiation Production Systems
5.2.3 Generator and Separation Production Systems
5.2.4 Electron Accelerator and Neutron Source Production Systems
5.2.5 Others
5.3 Market Segment by Production Route
5.3.1 World Nuclear Medicine Radioisotope Production Systems Production by Production Route (2021-2032)
5.3.2 World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route (2021-2032)
5.3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2032)
6 MARKET ANALYSIS BY ENERGY LEVEL
6.1 World Nuclear Medicine Radioisotope Production Systems Market Size Overview by Energy Level: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Energy Level
6.2.1 Compact Low Energy Systems (?20 MeV)
6.2.2 Medium Energy Multi Isotope Systems (20 to 35 MeV)
6.2.3 High Energy Isotope Production Systems (>35 MeV)
6.2.4 Others
6.3 Market Segment by Energy Level
6.3.1 World Nuclear Medicine Radioisotope Production Systems Production by Energy Level (2021-2032)
6.3.2 World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level (2021-2032)
6.3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Energy Level (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Nuclear Medicine Radioisotope Production Systems Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital Nuclear Medicine Centers
7.2.2 Commercial Radiopharmacies
7.2.3 National Isotope Production Centers
7.2.4 Research Institutes and Universities
7.2.5 Nuclear Reactor Facilities
7.2.6 Radiopharmaceutical CDMO Sites
7.2.7 Others
7.3 Market Segment by Application
7.3.1 World Nuclear Medicine Radioisotope Production Systems Production by Application (2021-2032)
7.3.2 World Nuclear Medicine Radioisotope Production Systems Production Value by Application (2021-2032)
7.3.3 World Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Ion Beam Applications SA
8.1.1 Ion Beam Applications SA Details
8.1.2 Ion Beam Applications SA Major Business
8.1.3 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product and Services
8.1.4 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Ion Beam Applications SA Recent Developments/Updates
8.1.6 Ion Beam Applications SA Competitive Strengths & Weaknesses
8.2 GE HealthCare Technologies Inc.
8.2.1 GE HealthCare Technologies Inc. Details
8.2.2 GE HealthCare Technologies Inc. Major Business
8.2.3 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
8.2.4 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 GE HealthCare Technologies Inc. Recent Developments/Updates
8.2.6 GE HealthCare Technologies Inc. Competitive Strengths & Weaknesses
8.3 Sumitomo Heavy Industries, Ltd.
8.3.1 Sumitomo Heavy Industries, Ltd. Details
8.3.2 Sumitomo Heavy Industries, Ltd. Major Business
8.3.3 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
8.3.4 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Sumitomo Heavy Industries, Ltd. Recent Developments/Updates
8.3.6 Sumitomo Heavy Industries, Ltd. Competitive Strengths & Weaknesses
8.4 Advanced Cyclotron Systems Inc.
8.4.1 Advanced Cyclotron Systems Inc. Details
8.4.2 Advanced Cyclotron Systems Inc. Major Business
8.4.3 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
8.4.4 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Advanced Cyclotron Systems Inc. Recent Developments/Updates
8.4.6 Advanced Cyclotron Systems Inc. Competitive Strengths & Weaknesses
8.5 Best Theratronics Ltd.
8.5.1 Best Theratronics Ltd. Details
8.5.2 Best Theratronics Ltd. Major Business
8.5.3 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
8.5.4 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Best Theratronics Ltd. Recent Developments/Updates
8.5.6 Best Theratronics Ltd. Competitive Strengths & Weaknesses
8.6 PMB SAS
8.6.1 PMB SAS Details
8.6.2 PMB SAS Major Business
8.6.3 PMB SAS Nuclear Medicine Radioisotope Production Systems Product and Services
8.6.4 PMB SAS Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 PMB SAS Recent Developments/Updates
8.6.6 PMB SAS Competitive Strengths & Weaknesses
8.7 Sichuan Longevous Beamtech Co., Ltd.
8.7.1 Sichuan Longevous Beamtech Co., Ltd. Details
8.7.2 Sichuan Longevous Beamtech Co., Ltd. Major Business
8.7.3 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
8.7.4 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Sichuan Longevous Beamtech Co., Ltd. Recent Developments/Updates
8.7.6 Sichuan Longevous Beamtech Co., Ltd. Competitive Strengths & Weaknesses
8.8 China Institute of Atomic Energy
8.8.1 China Institute of Atomic Energy Details
8.8.2 China Institute of Atomic Energy Major Business
8.8.3 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product and Services
8.8.4 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 China Institute of Atomic Energy Recent Developments/Updates
8.8.6 China Institute of Atomic Energy Competitive Strengths & Weaknesses
8.9 ARTMS Inc.
8.9.1 ARTMS Inc. Details
8.9.2 ARTMS Inc. Major Business
8.9.3 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
8.9.4 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 ARTMS Inc. Recent Developments/Updates
8.9.6 ARTMS Inc. Competitive Strengths & Weaknesses
8.10 Comecer S.p.A.
8.10.1 Comecer S.p.A. Details
8.10.2 Comecer S.p.A. Major Business
8.10.3 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
8.10.4 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Comecer S.p.A. Recent Developments/Updates
8.10.6 Comecer S.p.A. Competitive Strengths & Weaknesses
8.11 Tema Sinergie S.p.A.
8.11.1 Tema Sinergie S.p.A. Details
8.11.2 Tema Sinergie S.p.A. Major Business
8.11.3 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
8.11.4 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Tema Sinergie S.p.A. Recent Developments/Updates
8.11.6 Tema Sinergie S.p.A. Competitive Strengths & Weaknesses
8.12 Von Gahlen International B.V.
8.12.1 Von Gahlen International B.V. Details
8.12.2 Von Gahlen International B.V. Major Business
8.12.3 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product and Services
8.12.4 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Von Gahlen International B.V. Recent Developments/Updates
8.12.6 Von Gahlen International B.V. Competitive Strengths & Weaknesses
8.13 Trasis S.A.
8.13.1 Trasis S.A. Details
8.13.2 Trasis S.A. Major Business
8.13.3 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product and Services
8.13.4 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Trasis S.A. Recent Developments/Updates
8.13.6 Trasis S.A. Competitive Strengths & Weaknesses
8.14 Eckert & Ziegler Medical GmbH
8.14.1 Eckert & Ziegler Medical GmbH Details
8.14.2 Eckert & Ziegler Medical GmbH Major Business
8.14.3 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product and Services
8.14.4 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.14.5 Eckert & Ziegler Medical GmbH Recent Developments/Updates
8.14.6 Eckert & Ziegler Medical GmbH Competitive Strengths & Weaknesses
8.15 Kinectrics Inc.
8.15.1 Kinectrics Inc. Details
8.15.2 Kinectrics Inc. Major Business
8.15.3 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
8.15.4 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.15.5 Kinectrics Inc. Recent Developments/Updates
8.15.6 Kinectrics Inc. Competitive Strengths & Weaknesses
8.16 Framatome
8.16.1 Framatome Details
8.16.2 Framatome Major Business
8.16.3 Framatome Nuclear Medicine Radioisotope Production Systems Product and Services
8.16.4 Framatome Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.16.5 Framatome Recent Developments/Updates
8.16.6 Framatome Competitive Strengths & Weaknesses
8.17 NorthStar Medical Radioisotopes, LLC
8.17.1 NorthStar Medical Radioisotopes, LLC Details
8.17.2 NorthStar Medical Radioisotopes, LLC Major Business
8.17.3 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product and Services
8.17.4 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.17.5 NorthStar Medical Radioisotopes, LLC Recent Developments/Updates
8.17.6 NorthStar Medical Radioisotopes, LLC Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Nuclear Medicine Radioisotope Production Systems Industry Chain
9.2 Nuclear Medicine Radioisotope Production Systems Upstream Analysis
9.2.1 Nuclear Medicine Radioisotope Production Systems Core Raw Materials
9.2.2 Main Manufacturers of Nuclear Medicine Radioisotope Production Systems Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Nuclear Medicine Radioisotope Production Systems Production Mode
9.6 Nuclear Medicine Radioisotope Production Systems Procurement Model
9.7 Nuclear Medicine Radioisotope Production Systems Industry Sales Model and Sales Channels
9.7.1 Nuclear Medicine Radioisotope Production Systems Sales Model
9.7.2 Nuclear Medicine Radioisotope Production Systems Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Nuclear Medicine Radioisotope Production Systems Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Nuclear Medicine Radioisotope Production Systems Production Value by Region (2021-2026) & (USD Million)
Table 3. World Nuclear Medicine Radioisotope Production Systems Production Value by Region (2027-2032) & (USD Million)
Table 4. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Region (2021-2026)
Table 5. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Region (2027-2032)
Table 6. World Nuclear Medicine Radioisotope Production Systems Production by Region (2021-2026) & (Units)
Table 7. World Nuclear Medicine Radioisotope Production Systems Production by Region (2027-2032) & (Units)
Table 8. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Region (2021-2026)
Table 9. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Region (2027-2032)
Table 10. World Nuclear Medicine Radioisotope Production Systems Average Price by Region (2021-2026) & (K US$/Unit)
Table 11. World Nuclear Medicine Radioisotope Production Systems Average Price by Region (2027-2032) & (K US$/Unit)
Table 12. Nuclear Medicine Radioisotope Production Systems Major Market Trends
Table 13. World Nuclear Medicine Radioisotope Production Systems Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Nuclear Medicine Radioisotope Production Systems Consumption by Region (2021-2026) & (Units)
Table 15. World Nuclear Medicine Radioisotope Production Systems Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Nuclear Medicine Radioisotope Production Systems Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Nuclear Medicine Radioisotope Production Systems Producers in 2025
Table 18. World Nuclear Medicine Radioisotope Production Systems Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Nuclear Medicine Radioisotope Production Systems Producers in 2025
Table 20. World Nuclear Medicine Radioisotope Production Systems Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 21. Global Nuclear Medicine Radioisotope Production Systems Company Evaluation Quadrant
Table 22. World Nuclear Medicine Radioisotope Production Systems Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Nuclear Medicine Radioisotope Production Systems Production Site of Key Manufacturer
Table 24. Nuclear Medicine Radioisotope Production Systems Market: Company Product Type Footprint
Table 25. Nuclear Medicine Radioisotope Production Systems Market: Company Product Application Footprint
Table 26. Nuclear Medicine Radioisotope Production Systems Competitive Factors
Table 27. Nuclear Medicine Radioisotope Production Systems New Entrant and Capacity Expansion Plans
Table 28. Nuclear Medicine Radioisotope Production Systems Mergers & Acquisitions Activity
Table 29. United States VS China Nuclear Medicine Radioisotope Production Systems Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Nuclear Medicine Radioisotope Production Systems Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Nuclear Medicine Radioisotope Production Systems Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share (2021-2026)
Table 37. China Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share (2021-2026)
Table 42. Rest of World Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share (2021-2026)
Table 47. World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route, (USD Million), 2021 & 2025 & 2032
Table 48. World Nuclear Medicine Radioisotope Production Systems Production by Production Route (2021-2026) & (Units)
Table 49. World Nuclear Medicine Radioisotope Production Systems Production by Production Route (2027-2032) & (Units)
Table 50. World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route (2021-2026) & (USD Million)
Table 51. World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route (2027-2032) & (USD Million)
Table 52. World Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2026) & (K US$/Unit)
Table 53. World Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2027-2032) & (K US$/Unit)
Table 54. World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level, (USD Million), 2021 & 2025 & 2032
Table 55. World Nuclear Medicine Radioisotope Production Systems Production by Energy Level (2021-2026) & (Units)
Table 56. World Nuclear Medicine Radioisotope Production Systems Production by Energy Level (2027-2032) & (Units)
Table 57. World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level (2021-2026) & (USD Million)
Table 58. World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level (2027-2032) & (USD Million)
Table 59. World Nuclear Medicine Radioisotope Production Systems Average Price by Energy Level (2021-2026) & (K US$/Unit)
Table 60. World Nuclear Medicine Radioisotope Production Systems Average Price by Energy Level (2027-2032) & (K US$/Unit)
Table 61. World Nuclear Medicine Radioisotope Production Systems Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Nuclear Medicine Radioisotope Production Systems Production by Application (2021-2026) & (Units)
Table 63. World Nuclear Medicine Radioisotope Production Systems Production by Application (2027-2032) & (Units)
Table 64. World Nuclear Medicine Radioisotope Production Systems Production Value by Application (2021-2026) & (USD Million)
Table 65. World Nuclear Medicine Radioisotope Production Systems Production Value by Application (2027-2032) & (USD Million)
Table 66. World Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2026) & (K US$/Unit)
Table 67. World Nuclear Medicine Radioisotope Production Systems Average Price by Application (2027-2032) & (K US$/Unit)
Table 68. Ion Beam Applications SA Basic Information, Manufacturing Base and Competitors
Table 69. Ion Beam Applications SA Major Business
Table 70. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product and Services
Table 71. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Ion Beam Applications SA Recent Developments/Updates
Table 73. Ion Beam Applications SA Competitive Strengths & Weaknesses
Table 74. GE HealthCare Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 75. GE HealthCare Technologies Inc. Major Business
Table 76. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 77. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. GE HealthCare Technologies Inc. Recent Developments/Updates
Table 79. GE HealthCare Technologies Inc. Competitive Strengths & Weaknesses
Table 80. Sumitomo Heavy Industries, Ltd. Basic Information, Manufacturing Base and Competitors
Table 81. Sumitomo Heavy Industries, Ltd. Major Business
Table 82. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 83. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Sumitomo Heavy Industries, Ltd. Recent Developments/Updates
Table 85. Sumitomo Heavy Industries, Ltd. Competitive Strengths & Weaknesses
Table 86. Advanced Cyclotron Systems Inc. Basic Information, Manufacturing Base and Competitors
Table 87. Advanced Cyclotron Systems Inc. Major Business
Table 88. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 89. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Advanced Cyclotron Systems Inc. Recent Developments/Updates
Table 91. Advanced Cyclotron Systems Inc. Competitive Strengths & Weaknesses
Table 92. Best Theratronics Ltd. Basic Information, Manufacturing Base and Competitors
Table 93. Best Theratronics Ltd. Major Business
Table 94. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 95. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Best Theratronics Ltd. Recent Developments/Updates
Table 97. Best Theratronics Ltd. Competitive Strengths & Weaknesses
Table 98. PMB SAS Basic Information, Manufacturing Base and Competitors
Table 99. PMB SAS Major Business
Table 100. PMB SAS Nuclear Medicine Radioisotope Production Systems Product and Services
Table 101. PMB SAS Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. PMB SAS Recent Developments/Updates
Table 103. PMB SAS Competitive Strengths & Weaknesses
Table 104. Sichuan Longevous Beamtech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 105. Sichuan Longevous Beamtech Co., Ltd. Major Business
Table 106. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 107. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Sichuan Longevous Beamtech Co., Ltd. Recent Developments/Updates
Table 109. Sichuan Longevous Beamtech Co., Ltd. Competitive Strengths & Weaknesses
Table 110. China Institute of Atomic Energy Basic Information, Manufacturing Base and Competitors
Table 111. China Institute of Atomic Energy Major Business
Table 112. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product and Services
Table 113. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. China Institute of Atomic Energy Recent Developments/Updates
Table 115. China Institute of Atomic Energy Competitive Strengths & Weaknesses
Table 116. ARTMS Inc. Basic Information, Manufacturing Base and Competitors
Table 117. ARTMS Inc. Major Business
Table 118. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 119. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. ARTMS Inc. Recent Developments/Updates
Table 121. ARTMS Inc. Competitive Strengths & Weaknesses
Table 122. Comecer S.p.A. Basic Information, Manufacturing Base and Competitors
Table 123. Comecer S.p.A. Major Business
Table 124. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 125. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Comecer S.p.A. Recent Developments/Updates
Table 127. Comecer S.p.A. Competitive Strengths & Weaknesses
Table 128. Tema Sinergie S.p.A. Basic Information, Manufacturing Base and Competitors
Table 129. Tema Sinergie S.p.A. Major Business
Table 130. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 131. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Tema Sinergie S.p.A. Recent Developments/Updates
Table 133. Tema Sinergie S.p.A. Competitive Strengths & Weaknesses
Table 134. Von Gahlen International B.V. Basic Information, Manufacturing Base and Competitors
Table 135. Von Gahlen International B.V. Major Business
Table 136. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 137. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Von Gahlen International B.V. Recent Developments/Updates
Table 139. Von Gahlen International B.V. Competitive Strengths & Weaknesses
Table 140. Trasis S.A. Basic Information, Manufacturing Base and Competitors
Table 141. Trasis S.A. Major Business
Table 142. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 143. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Trasis S.A. Recent Developments/Updates
Table 145. Trasis S.A. Competitive Strengths & Weaknesses
Table 146. Eckert & Ziegler Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 147. Eckert & Ziegler Medical GmbH Major Business
Table 148. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product and Services
Table 149. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Eckert & Ziegler Medical GmbH Recent Developments/Updates
Table 151. Eckert & Ziegler Medical GmbH Competitive Strengths & Weaknesses
Table 152. Kinectrics Inc. Basic Information, Manufacturing Base and Competitors
Table 153. Kinectrics Inc. Major Business
Table 154. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 155. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. Kinectrics Inc. Recent Developments/Updates
Table 157. Kinectrics Inc. Competitive Strengths & Weaknesses
Table 158. Framatome Basic Information, Manufacturing Base and Competitors
Table 159. Framatome Major Business
Table 160. Framatome Nuclear Medicine Radioisotope Production Systems Product and Services
Table 161. Framatome Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 162. Framatome Recent Developments/Updates
Table 163. Framatome Competitive Strengths & Weaknesses
Table 164. NorthStar Medical Radioisotopes, LLC Basic Information, Manufacturing Base and Competitors
Table 165. NorthStar Medical Radioisotopes, LLC Major Business
Table 166. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product and Services
Table 167. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 168. NorthStar Medical Radioisotopes, LLC Recent Developments/Updates
Table 169. NorthStar Medical Radioisotopes, LLC Competitive Strengths & Weaknesses
Table 170. Global Key Players of Nuclear Medicine Radioisotope Production Systems Upstream (Raw Materials)
Table 171. Global Nuclear Medicine Radioisotope Production Systems Typical Customers
Table 172. Nuclear Medicine Radioisotope Production Systems Typical Distributors
Table 1. World Nuclear Medicine Radioisotope Production Systems Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Nuclear Medicine Radioisotope Production Systems Production Value by Region (2021-2026) & (USD Million)
Table 3. World Nuclear Medicine Radioisotope Production Systems Production Value by Region (2027-2032) & (USD Million)
Table 4. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Region (2021-2026)
Table 5. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Region (2027-2032)
Table 6. World Nuclear Medicine Radioisotope Production Systems Production by Region (2021-2026) & (Units)
Table 7. World Nuclear Medicine Radioisotope Production Systems Production by Region (2027-2032) & (Units)
Table 8. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Region (2021-2026)
Table 9. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Region (2027-2032)
Table 10. World Nuclear Medicine Radioisotope Production Systems Average Price by Region (2021-2026) & (K US$/Unit)
Table 11. World Nuclear Medicine Radioisotope Production Systems Average Price by Region (2027-2032) & (K US$/Unit)
Table 12. Nuclear Medicine Radioisotope Production Systems Major Market Trends
Table 13. World Nuclear Medicine Radioisotope Production Systems Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Nuclear Medicine Radioisotope Production Systems Consumption by Region (2021-2026) & (Units)
Table 15. World Nuclear Medicine Radioisotope Production Systems Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Nuclear Medicine Radioisotope Production Systems Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Nuclear Medicine Radioisotope Production Systems Producers in 2025
Table 18. World Nuclear Medicine Radioisotope Production Systems Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Nuclear Medicine Radioisotope Production Systems Producers in 2025
Table 20. World Nuclear Medicine Radioisotope Production Systems Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 21. Global Nuclear Medicine Radioisotope Production Systems Company Evaluation Quadrant
Table 22. World Nuclear Medicine Radioisotope Production Systems Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Nuclear Medicine Radioisotope Production Systems Production Site of Key Manufacturer
Table 24. Nuclear Medicine Radioisotope Production Systems Market: Company Product Type Footprint
Table 25. Nuclear Medicine Radioisotope Production Systems Market: Company Product Application Footprint
Table 26. Nuclear Medicine Radioisotope Production Systems Competitive Factors
Table 27. Nuclear Medicine Radioisotope Production Systems New Entrant and Capacity Expansion Plans
Table 28. Nuclear Medicine Radioisotope Production Systems Mergers & Acquisitions Activity
Table 29. United States VS China Nuclear Medicine Radioisotope Production Systems Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Nuclear Medicine Radioisotope Production Systems Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Nuclear Medicine Radioisotope Production Systems Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share (2021-2026)
Table 37. China Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share (2021-2026)
Table 42. Rest of World Based Nuclear Medicine Radioisotope Production Systems Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share (2021-2026)
Table 47. World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route, (USD Million), 2021 & 2025 & 2032
Table 48. World Nuclear Medicine Radioisotope Production Systems Production by Production Route (2021-2026) & (Units)
Table 49. World Nuclear Medicine Radioisotope Production Systems Production by Production Route (2027-2032) & (Units)
Table 50. World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route (2021-2026) & (USD Million)
Table 51. World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route (2027-2032) & (USD Million)
Table 52. World Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2026) & (K US$/Unit)
Table 53. World Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2027-2032) & (K US$/Unit)
Table 54. World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level, (USD Million), 2021 & 2025 & 2032
Table 55. World Nuclear Medicine Radioisotope Production Systems Production by Energy Level (2021-2026) & (Units)
Table 56. World Nuclear Medicine Radioisotope Production Systems Production by Energy Level (2027-2032) & (Units)
Table 57. World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level (2021-2026) & (USD Million)
Table 58. World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level (2027-2032) & (USD Million)
Table 59. World Nuclear Medicine Radioisotope Production Systems Average Price by Energy Level (2021-2026) & (K US$/Unit)
Table 60. World Nuclear Medicine Radioisotope Production Systems Average Price by Energy Level (2027-2032) & (K US$/Unit)
Table 61. World Nuclear Medicine Radioisotope Production Systems Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Nuclear Medicine Radioisotope Production Systems Production by Application (2021-2026) & (Units)
Table 63. World Nuclear Medicine Radioisotope Production Systems Production by Application (2027-2032) & (Units)
Table 64. World Nuclear Medicine Radioisotope Production Systems Production Value by Application (2021-2026) & (USD Million)
Table 65. World Nuclear Medicine Radioisotope Production Systems Production Value by Application (2027-2032) & (USD Million)
Table 66. World Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2026) & (K US$/Unit)
Table 67. World Nuclear Medicine Radioisotope Production Systems Average Price by Application (2027-2032) & (K US$/Unit)
Table 68. Ion Beam Applications SA Basic Information, Manufacturing Base and Competitors
Table 69. Ion Beam Applications SA Major Business
Table 70. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product and Services
Table 71. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Ion Beam Applications SA Recent Developments/Updates
Table 73. Ion Beam Applications SA Competitive Strengths & Weaknesses
Table 74. GE HealthCare Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 75. GE HealthCare Technologies Inc. Major Business
Table 76. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 77. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. GE HealthCare Technologies Inc. Recent Developments/Updates
Table 79. GE HealthCare Technologies Inc. Competitive Strengths & Weaknesses
Table 80. Sumitomo Heavy Industries, Ltd. Basic Information, Manufacturing Base and Competitors
Table 81. Sumitomo Heavy Industries, Ltd. Major Business
Table 82. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 83. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Sumitomo Heavy Industries, Ltd. Recent Developments/Updates
Table 85. Sumitomo Heavy Industries, Ltd. Competitive Strengths & Weaknesses
Table 86. Advanced Cyclotron Systems Inc. Basic Information, Manufacturing Base and Competitors
Table 87. Advanced Cyclotron Systems Inc. Major Business
Table 88. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 89. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Advanced Cyclotron Systems Inc. Recent Developments/Updates
Table 91. Advanced Cyclotron Systems Inc. Competitive Strengths & Weaknesses
Table 92. Best Theratronics Ltd. Basic Information, Manufacturing Base and Competitors
Table 93. Best Theratronics Ltd. Major Business
Table 94. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 95. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Best Theratronics Ltd. Recent Developments/Updates
Table 97. Best Theratronics Ltd. Competitive Strengths & Weaknesses
Table 98. PMB SAS Basic Information, Manufacturing Base and Competitors
Table 99. PMB SAS Major Business
Table 100. PMB SAS Nuclear Medicine Radioisotope Production Systems Product and Services
Table 101. PMB SAS Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. PMB SAS Recent Developments/Updates
Table 103. PMB SAS Competitive Strengths & Weaknesses
Table 104. Sichuan Longevous Beamtech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 105. Sichuan Longevous Beamtech Co., Ltd. Major Business
Table 106. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 107. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Sichuan Longevous Beamtech Co., Ltd. Recent Developments/Updates
Table 109. Sichuan Longevous Beamtech Co., Ltd. Competitive Strengths & Weaknesses
Table 110. China Institute of Atomic Energy Basic Information, Manufacturing Base and Competitors
Table 111. China Institute of Atomic Energy Major Business
Table 112. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product and Services
Table 113. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. China Institute of Atomic Energy Recent Developments/Updates
Table 115. China Institute of Atomic Energy Competitive Strengths & Weaknesses
Table 116. ARTMS Inc. Basic Information, Manufacturing Base and Competitors
Table 117. ARTMS Inc. Major Business
Table 118. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 119. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. ARTMS Inc. Recent Developments/Updates
Table 121. ARTMS Inc. Competitive Strengths & Weaknesses
Table 122. Comecer S.p.A. Basic Information, Manufacturing Base and Competitors
Table 123. Comecer S.p.A. Major Business
Table 124. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 125. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Comecer S.p.A. Recent Developments/Updates
Table 127. Comecer S.p.A. Competitive Strengths & Weaknesses
Table 128. Tema Sinergie S.p.A. Basic Information, Manufacturing Base and Competitors
Table 129. Tema Sinergie S.p.A. Major Business
Table 130. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 131. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Tema Sinergie S.p.A. Recent Developments/Updates
Table 133. Tema Sinergie S.p.A. Competitive Strengths & Weaknesses
Table 134. Von Gahlen International B.V. Basic Information, Manufacturing Base and Competitors
Table 135. Von Gahlen International B.V. Major Business
Table 136. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 137. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Von Gahlen International B.V. Recent Developments/Updates
Table 139. Von Gahlen International B.V. Competitive Strengths & Weaknesses
Table 140. Trasis S.A. Basic Information, Manufacturing Base and Competitors
Table 141. Trasis S.A. Major Business
Table 142. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 143. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Trasis S.A. Recent Developments/Updates
Table 145. Trasis S.A. Competitive Strengths & Weaknesses
Table 146. Eckert & Ziegler Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 147. Eckert & Ziegler Medical GmbH Major Business
Table 148. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product and Services
Table 149. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Eckert & Ziegler Medical GmbH Recent Developments/Updates
Table 151. Eckert & Ziegler Medical GmbH Competitive Strengths & Weaknesses
Table 152. Kinectrics Inc. Basic Information, Manufacturing Base and Competitors
Table 153. Kinectrics Inc. Major Business
Table 154. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product and Services
Table 155. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. Kinectrics Inc. Recent Developments/Updates
Table 157. Kinectrics Inc. Competitive Strengths & Weaknesses
Table 158. Framatome Basic Information, Manufacturing Base and Competitors
Table 159. Framatome Major Business
Table 160. Framatome Nuclear Medicine Radioisotope Production Systems Product and Services
Table 161. Framatome Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 162. Framatome Recent Developments/Updates
Table 163. Framatome Competitive Strengths & Weaknesses
Table 164. NorthStar Medical Radioisotopes, LLC Basic Information, Manufacturing Base and Competitors
Table 165. NorthStar Medical Radioisotopes, LLC Major Business
Table 166. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product and Services
Table 167. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 168. NorthStar Medical Radioisotopes, LLC Recent Developments/Updates
Table 169. NorthStar Medical Radioisotopes, LLC Competitive Strengths & Weaknesses
Table 170. Global Key Players of Nuclear Medicine Radioisotope Production Systems Upstream (Raw Materials)
Table 171. Global Nuclear Medicine Radioisotope Production Systems Typical Customers
Table 172. Nuclear Medicine Radioisotope Production Systems Typical Distributors
LIST OF FIGURES
Figure 1. Nuclear Medicine Radioisotope Production Systems Picture
Figure 2. World Nuclear Medicine Radioisotope Production Systems Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nuclear Medicine Radioisotope Production Systems Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 5. World Nuclear Medicine Radioisotope Production Systems Average Price (2021-2032) & (K US$/Unit)
Figure 6. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Region (2021-2032)
Figure 7. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Region (2021-2032)
Figure 8. North America Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 9. Europe Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 10. China Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 11. Japan Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 12. Nuclear Medicine Radioisotope Production Systems Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 15. World Nuclear Medicine Radioisotope Production Systems Consumption Market Share by Region (2021-2032)
Figure 16. United States Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 17. China Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 18. Europe Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 19. Japan Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 20. South Korea Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 21. ASEAN Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 22. India Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Nuclear Medicine Radioisotope Production Systems by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nuclear Medicine Radioisotope Production Systems Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nuclear Medicine Radioisotope Production Systems Markets in 2025
Figure 26. United States VS China: Nuclear Medicine Radioisotope Production Systems Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Nuclear Medicine Radioisotope Production Systems Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nuclear Medicine Radioisotope Production Systems Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share 2025
Figure 30. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share 2025
Figure 32. World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route, (USD Million), 2021 & 2025 & 2032
Figure 33. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Production Route in 2025
Figure 34. Cyclotron based Production Systems
Figure 35. Reactor Irradiation Production Systems
Figure 36. Generator and Separation Production Systems
Figure 37. Electron Accelerator and Neutron Source Production Systems
Figure 38. Others
Figure 39. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Production Route (2021-2032)
Figure 40. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Production Route (2021-2032)
Figure 41. World Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2032) & (K US$/Unit)
Figure 42. World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level, (USD Million), 2021 & 2025 & 2032
Figure 43. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Energy Level in 2025
Figure 44. Compact Low Energy Systems (?20 MeV)
Figure 45. Medium Energy Multi Isotope Systems (20 to 35 MeV)
Figure 46. High Energy Isotope Production Systems (>35 MeV)
Figure 47. Others
Figure 48. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Energy Level (2021-2032)
Figure 49. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Energy Level (2021-2032)
Figure 50. World Nuclear Medicine Radioisotope Production Systems Average Price by Energy Level (2021-2032) & (K US$/Unit)
Figure 51. World Nuclear Medicine Radioisotope Production Systems Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Application in 2025
Figure 53. Hospital Nuclear Medicine Centers
Figure 54. Commercial Radiopharmacies
Figure 55. National Isotope Production Centers
Figure 56. Research Institutes and Universities
Figure 57. Nuclear Reactor Facilities
Figure 58. Radiopharmaceutical CDMO Sites
Figure 59. Others
Figure 60. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Application (2021-2032)
Figure 61. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Application (2021-2032)
Figure 62. World Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2032) & (K US$/Unit)
Figure 63. Nuclear Medicine Radioisotope Production Systems Industry Chain
Figure 64. Nuclear Medicine Radioisotope Production Systems Procurement Model
Figure 65. Nuclear Medicine Radioisotope Production Systems Sales Model
Figure 66. Nuclear Medicine Radioisotope Production Systems Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Nuclear Medicine Radioisotope Production Systems Picture
Figure 2. World Nuclear Medicine Radioisotope Production Systems Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nuclear Medicine Radioisotope Production Systems Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 5. World Nuclear Medicine Radioisotope Production Systems Average Price (2021-2032) & (K US$/Unit)
Figure 6. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Region (2021-2032)
Figure 7. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Region (2021-2032)
Figure 8. North America Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 9. Europe Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 10. China Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 11. Japan Nuclear Medicine Radioisotope Production Systems Production (2021-2032) & (Units)
Figure 12. Nuclear Medicine Radioisotope Production Systems Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 15. World Nuclear Medicine Radioisotope Production Systems Consumption Market Share by Region (2021-2032)
Figure 16. United States Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 17. China Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 18. Europe Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 19. Japan Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 20. South Korea Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 21. ASEAN Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 22. India Nuclear Medicine Radioisotope Production Systems Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Nuclear Medicine Radioisotope Production Systems by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nuclear Medicine Radioisotope Production Systems Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nuclear Medicine Radioisotope Production Systems Markets in 2025
Figure 26. United States VS China: Nuclear Medicine Radioisotope Production Systems Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Nuclear Medicine Radioisotope Production Systems Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nuclear Medicine Radioisotope Production Systems Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share 2025
Figure 30. China Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Nuclear Medicine Radioisotope Production Systems Production Market Share 2025
Figure 32. World Nuclear Medicine Radioisotope Production Systems Production Value by Production Route, (USD Million), 2021 & 2025 & 2032
Figure 33. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Production Route in 2025
Figure 34. Cyclotron based Production Systems
Figure 35. Reactor Irradiation Production Systems
Figure 36. Generator and Separation Production Systems
Figure 37. Electron Accelerator and Neutron Source Production Systems
Figure 38. Others
Figure 39. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Production Route (2021-2032)
Figure 40. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Production Route (2021-2032)
Figure 41. World Nuclear Medicine Radioisotope Production Systems Average Price by Production Route (2021-2032) & (K US$/Unit)
Figure 42. World Nuclear Medicine Radioisotope Production Systems Production Value by Energy Level, (USD Million), 2021 & 2025 & 2032
Figure 43. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Energy Level in 2025
Figure 44. Compact Low Energy Systems (?20 MeV)
Figure 45. Medium Energy Multi Isotope Systems (20 to 35 MeV)
Figure 46. High Energy Isotope Production Systems (>35 MeV)
Figure 47. Others
Figure 48. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Energy Level (2021-2032)
Figure 49. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Energy Level (2021-2032)
Figure 50. World Nuclear Medicine Radioisotope Production Systems Average Price by Energy Level (2021-2032) & (K US$/Unit)
Figure 51. World Nuclear Medicine Radioisotope Production Systems Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Application in 2025
Figure 53. Hospital Nuclear Medicine Centers
Figure 54. Commercial Radiopharmacies
Figure 55. National Isotope Production Centers
Figure 56. Research Institutes and Universities
Figure 57. Nuclear Reactor Facilities
Figure 58. Radiopharmaceutical CDMO Sites
Figure 59. Others
Figure 60. World Nuclear Medicine Radioisotope Production Systems Production Market Share by Application (2021-2032)
Figure 61. World Nuclear Medicine Radioisotope Production Systems Production Value Market Share by Application (2021-2032)
Figure 62. World Nuclear Medicine Radioisotope Production Systems Average Price by Application (2021-2032) & (K US$/Unit)
Figure 63. Nuclear Medicine Radioisotope Production Systems Industry Chain
Figure 64. Nuclear Medicine Radioisotope Production Systems Procurement Model
Figure 65. Nuclear Medicine Radioisotope Production Systems Sales Model
Figure 66. Nuclear Medicine Radioisotope Production Systems Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
